Clinical Trials Logo

Constipation Chronic Idiopathic clinical trials

View clinical trials related to Constipation Chronic Idiopathic.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06082622 Completed - Clinical trials for Constipation Chronic Idiopathic

Evaluation of the Triple Management Program in the Management of Functional Chronic Constipation in Children

Start date: March 2016
Phase: N/A
Study type: Interventional

Abstract Background: Chronic constipation is a common disease in children, 3% all children visit gastroenterology clinics with different types and complains. It is very harsh, time consuming and psychological problems to a child and all his family members. Objective: To find a simple and effective training method that manages the bowel habits intervals both easy and effective for both child and parents. Patients and methods: A training program for 18 weeks in 180 children with follow up every three months for 3 years between March 2016 and April 2019. Two groups were assembled, Group (A) with 90 children managed by the 3 Role program and Group (B) formed of the other 90 children treated with traditional guidelines. All types of functional Constipations and all ages are distributed equally in the two Groups. The Parents were taught to Hang a Sign Saying (One Bowel habit by third day at least) and then follow the Triple method program for 18 weeks. First follow up is on the 3rd week. The triple axis program is working on mental, colon elasticity and fecal consistency. The Mental axis is done by bowel interval sets in fixed 3 times for 10 minutes in each, Colon contents by certain diet protocol and colon motility and elasticity by drugs.

NCT ID: NCT05129618 Completed - Clinical trials for Constipation Chronic Idiopathic

Tolerability Study of Panosyl Isomaltooligosaccharides (PIMO), in Subjects With Chronic Idiopathic Constipation (CIC)

Start date: September 23, 2021
Phase: N/A
Study type: Interventional

This is a randomized, double blind, placebo controlled trial to evaluate the tolerability of MHS 1031. Tolerability will be assessed using the change in complete spontaneous bowel movements (CSBM), PRO questionnaires, concomitant medication assessments, and assessment of adverse events, from baseline (determined during Screening Phase) to Week 8 (Day 56). The primary analysis will be conducted to assess the tolerability of MHS 1031 product and of the formulated placebo in randomized subjects with CIC diagnosed according to a modified Rome IV criteria.

NCT ID: NCT05036369 Completed - Clinical trials for Constipation Chronic Idiopathic

Vibrant Capsule vs. Placebo for Patient Suffering From Constipation

Capsule
Start date: July 5, 2021
Phase: N/A
Study type: Interventional

The objectives are to assess the efficacy and safety of Vibrant capsule administered twice a week

NCT ID: NCT04262752 Completed - Constipation Clinical Trials

MOWOOT Device to Treat Constipation in Adults

Start date: January 11, 2018
Phase: N/A
Study type: Interventional

The aim was to assess the safety and effectiveness of the automatic colon-specific massage with the MOWOOT device for patients suffering from chronic constipation due to Multiple Sclerosis, Parkinson Disease (NBD) or other unknown causes (Idiopathic).The hypothesis is that this treatment administered daily in home-use settings could ameliorate constipation in chronically affected people.